Ken Griffin
SNTI icon

Ken Griffin’s Senti Biosciences Holdings SNTI Stock Holding History

Ken Griffin’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-82,753
Closed -$117K – 13967
2025
Q3 		$117K Buy
+82,753
New +$138K ﹤0.01% 11732
2024
Q2 		– Sell
-7,901
Closed -$29.8K – 15312
2024
Q1 		$29.8K Buy
7,901
+3,531
+81% +$15.8K ﹤0.01% 12703
2023
Q4 		$28.8K Buy
+4,370
New +$17K ﹤0.01% 12302
2022
Q1 		– Sell
-1,507
Closed -$149K – 14507
2021
Q4 		$149K Buy
+1,507
New +$150K ﹤0.01% 12268
2021
Q3 		– Sell
-18,040
Closed -$1.79M – 14588
2021
Q2 		$1.79M Buy
+18,040
New +$1.8M ﹤0.01% 6869

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MG
MSOP GP Menlo Park, California $439M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's SNTI Position: Q4 2025 in Review

Ken Griffin sold out of Senti Biosciences Holdings (SNTI) in Q4 2025, closing a stake of 82,753 shares — an estimated $117K sold.

Ken Griffin first reported a position in SNTI in Q2 2021 and held it in 5 quarters. The position peaked at $1.79M in Q2 2021. 15 funds tracked by Wall St. Rank hold SNTI as of Q4 2025.

  • Ken Griffin reported no remaining Senti Biosciences Holdings position as of Q4 2025 after selling out during the quarter.
  • Ken Griffin sold 82,753 Senti Biosciences Holdings shares in Q4 2025, an estimated $117K.
  • Ken Griffin first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 5 quarters.
  • Ken Griffin's Senti Biosciences Holdings position peaked at $1.79M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.